Skip to main content
. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4

Davies 1997.

Methods Double‐blind, placebo‐controlled, parallel group RCT
Participants 17 male, 7 female, age 18 to 90 years
Eligibility criteria: community‐acquired pneumonia, sepsis and a parapneumonic effusion as defined by the following criteria: purulent fluid with evidence of bacteria on microscopy or culture, pH < 7.1, lactate dehydrogenase > 1000 IU/L, pleural fluid/blood glucose ratio < 0.25 with loculation/septation of pleural fluid on CT.
Exclusion criteria: previous treatment with streptokinase within the previous 2 years, bleeding diathesis, and significant haemorrhage or stroke within the previous 6 months, or disease making survival < 2 months unlikely.
Participants all received antibiotics which were appropriate for the organisms cultured, or broad‐spectrum antibiotics to cover gram‐positive, gram‐negative and anaerobic organisms.
Interventions Daily intrapleural streptokinase 250,000 IU for 3 days versus normal saline.
Intervention group: intrapleural streptokinase 250,000 IU via a 14 French van Sonnenberg catheter in 20 mL normal saline on 3 consecutive days.
Control group: 20 mL normal saline in the control group.
The drain was then clamped for 2 hours. Both groups received a background of 6‐hourly 20 mL normal saline flushes until the intercostal catheter was removed. The catheters were inserted into the most dependent portion of the effusion or into the largest loculation. Continuous suction of −20 cmH₂O was applied.
The intercostal catheter was removed after the 5th day and when the amount of fluid drained was < 150 mL for 2 consecutive days. Further aspiration or catheter drainage was at the discretion of the admitting physician.
Follow‐up: 3 years.
Outcomes
  1. Days to defervescence

  2. Duration of hospital stay

  3. Duration of pleural drainage

  4. Pleural fluid amount over first 3 day's treatment

  5. Improvement in chest radiograph

  6. Referral for surgery

  7. Death

  8. Overall treatment failure

  9. Side effects of treatment

  10. Haemorrhagic complications

Notes Parapneumonic effusion only.
Funding sources not identified in published manuscript.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomisation sequence (author correspondence).
Allocation concealment (selection bias) Unclear risk Information not available.
Blinding (performance bias and detection bias) 
 All outcomes Low risk Double‐blind author correspondence.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Radiographs scored by blinded radiologists. Not specified for other outcomes.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk "Withdrawals" were referrals for surgery — an outcome.
Selective reporting (reporting bias) Low risk All outcomes described in Methods fully reported. Original protocol unavailable to confirm original primary outcomes.
Other bias Low risk Nil identified.